<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34831228</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>23</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4409</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>11</Issue><PubDate><Year>2021</Year><Month>Nov</Month><Day>03</Day></PubDate></JournalIssue><Title>Cells</Title><ISOAbbreviation>Cells</ISOAbbreviation></Journal><ArticleTitle>Dysfunction of RNA/RNA-Binding Proteins in ALS Astrocytes and Microglia.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">3005</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/cells10113005</ELocationID><Abstract><AbstractText>Amyotrophic Lateral Sclerosis is a neurological disease that primarily affects motor neurons in the cortex, brainstem, and spinal cord. The process that leads to motor neuron degeneration is strongly influenced by non-motor neuronal events that occur in a variety of cell types. Among these, neuroinflammatory processes mediated by activated astrocytes and microglia play a relevant role. In recent years, it has become clear that dysregulation of essential steps of RNA metabolism, as a consequence of alterations in RNA-binding proteins (RBPs), is a central event in the degeneration of motor neurons. Yet, a causal link between dysfunctional RNA metabolism and the neuroinflammatory processes mediated by astrocytes and microglia in ALS has been poorly defined. In this review, we will discuss the available evidence showing that RBPs and associated RNA processing are affected in ALS astrocytes and microglia, and the possible mechanisms involved in these events.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rossi</LastName><ForeName>Simona</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-5038-0767</Identifier><AffiliationInfo><Affiliation>Istituto di Farmacologia Traslazionale, CNR, 00133 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cozzolino</LastName><ForeName>Mauro</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-0342-8961</Identifier><AffiliationInfo><Affiliation>Istituto di Farmacologia Traslazionale, CNR, 00133 Rome, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>SPLICEALS</GrantID><Agency>Fondazione Italiana di Ricerca per la Sclerosi Laterale Amiotrofica</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>11</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cells</MedlineTA><NlmUniqueID>101600052</NlmUniqueID><ISSNLinking>2073-4409</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016601">RNA-Binding Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001253" MajorTopicYN="N">Astrocytes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017628" MajorTopicYN="N">Microglia</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016601" MajorTopicYN="N">RNA-Binding Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic Lateral Sclerosis</Keyword><Keyword MajorTopicYN="N">C9orf72</Keyword><Keyword MajorTopicYN="N">FUS</Keyword><Keyword MajorTopicYN="N">RNA metabolism</Keyword><Keyword MajorTopicYN="N">RNA-binding proteins</Keyword><Keyword MajorTopicYN="N">TDP-43</Keyword><Keyword MajorTopicYN="N">astrocytes</Keyword><Keyword MajorTopicYN="N">microglia</Keyword><Keyword MajorTopicYN="N">neuroinflammation</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>9</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>10</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>11</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>11</Month><Day>27</Day><Hour>1</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>11</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34831228</ArticleId><ArticleId IdType="pmc">PMC8616248</ArticleId><ArticleId IdType="doi">10.3390/cells10113005</ArticleId><ArticleId IdType="pii">cells10113005</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Masrori P., van Damme P. Amyotrophic lateral sclerosis: A clinical review. Eur. J. Neurol. 2020;27:1918&#x2013;1929. doi: 10.1111/ene.14393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14393</ArticleId><ArticleId IdType="pmc">PMC7540334</ArticleId><ArticleId IdType="pubmed">32526057</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Es M., Hardiman O., Chio A., Al-Chalabi A., Pasterkamp R.J., Veldink J.H., van den Berg L.H. Amyotrophic lateral sclerosis. Lancet. 2017;390:2084&#x2013;2098. doi: 10.1016/S0140-6736(17)31287-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)31287-4</ArticleId><ArticleId IdType="pubmed">28552366</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown R.H., Jr., Al-Chalabi A. Amyotrophic lateral sclerosis. N. Engl. J. Med. 2017;377:1602. doi: 10.1056/NEJMra1603471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">29045202</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim G., Gautier O., Tassoni-Tsuchida E., Ma X.R., Gitler A.D. ALS genetics: Gains, losses, and implications for future therapies. Neuron. 2020;108:822&#x2013;842. doi: 10.1016/j.neuron.2020.08.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2020.08.022</ArticleId><ArticleId IdType="pmc">PMC7736125</ArticleId><ArticleId IdType="pubmed">32931756</ArticleId></ArticleIdList></Reference><Reference><Citation>Mejzini R., Flynn L., Pitout I.L., Fletcher S., Wilton S., Akkari P.A. ALS genetics, mechanisms, and therapeutics: Where are we now? Front. Neurosci. 2019;13:1310. doi: 10.3389/fnins.2019.01310.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.01310</ArticleId><ArticleId IdType="pmc">PMC6909825</ArticleId><ArticleId IdType="pubmed">31866818</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P.C., Hentati A., Donaldson D.H., Goto J., O&#x2019;Regan J.P., Deng H.-X., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59&#x2013;62. doi: 10.1038/362059a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilieva H., Polymenidou M., Cleveland D.W. Non&#x2013;cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J. Cell Biol. 2009;187:761&#x2013;772. doi: 10.1083/jcb.200908164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200908164</ArticleId><ArticleId IdType="pmc">PMC2806318</ArticleId><ArticleId IdType="pubmed">19951898</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H., Kankel M.W., Su S.C., Han S.W.S., Ofengeim D. Exploring the genetics and non-cell autonomous mechanisms underlying ALS/FTLD. Cell Death Differ. 2018;25:648&#x2013;662. doi: 10.1038/s41418-018-0060-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-018-0060-4</ArticleId><ArticleId IdType="pmc">PMC5864209</ArticleId><ArticleId IdType="pubmed">29459769</ArticleId></ArticleIdList></Reference><Reference><Citation>Garofalo S., Cocozza G., Porzia A., Inghilleri M., Raspa M., Scavizzi F., Aronica E., Bernardini G., Peng L., Ransohoff R.M., et al. Natural killer cells modulate motor neuron-immune cell cross talk in models of amyotrophic lateral sclerosis. Nat. Commun. 2020;11:1&#x2013;16. doi: 10.1038/s41467-020-15644-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-15644-8</ArticleId><ArticleId IdType="pmc">PMC7156729</ArticleId><ArticleId IdType="pubmed">32286313</ArticleId></ArticleIdList></Reference><Reference><Citation>Coque E., Salsac C., Espinosa-Carrasco G., Varga B., Degauque N., Cadoux M., Crab&#xe9; R., Virenque A., Soulard C., Fierle J.K., et al. Cytotoxic CD8+ T lymphocytes expressing ALS-causing SOD1 mutant selectively trigger death of spinal motoneurons. Proc. Natl. Acad. Sci. USA. 2019;116:2312&#x2013;2317. doi: 10.1073/pnas.1815961116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1815961116</ArticleId><ArticleId IdType="pmc">PMC6369778</ArticleId><ArticleId IdType="pubmed">30674678</ArticleId></ArticleIdList></Reference><Reference><Citation>Butti Z., Patten S.A. RNA dysregulation in amyotrophic lateral sclerosis. Front. Genet. 2019;9:712. doi: 10.3389/fgene.2018.00712.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2018.00712</ArticleId><ArticleId IdType="pmc">PMC6349704</ArticleId><ArticleId IdType="pubmed">30723494</ArticleId></ArticleIdList></Reference><Reference><Citation>Nussbacher J.K., Tabet R., Yeo G.W., Lagier-Tourenne C. Disruption of RNA metabolism in neurological diseases and emerging therapeutic interventions. Neuron. 2019;102:294&#x2013;320. doi: 10.1016/j.neuron.2019.03.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.03.014</ArticleId><ArticleId IdType="pmc">PMC6545120</ArticleId><ArticleId IdType="pubmed">30998900</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasile F., Dossi E., Rouach N. Human astrocytes: Structure and functions in the healthy brain. Brain Struct. Funct. 2017;222:2017&#x2013;2029. doi: 10.1007/s00429-017-1383-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00429-017-1383-5</ArticleId><ArticleId IdType="pmc">PMC5504258</ArticleId><ArticleId IdType="pubmed">28280934</ArticleId></ArticleIdList></Reference><Reference><Citation>Salter M.W., Stevens B. Microglia emerge as central players in brain disease. Nat. Med. 2017;23:1018&#x2013;1027. doi: 10.1038/nm.4397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4397</ArticleId><ArticleId IdType="pubmed">28886007</ArticleId></ArticleIdList></Reference><Reference><Citation>Ransohoff R.M. A polarizing question: Do M1 and M2 microglia exist? Nat. Neurosci. 2016;19:987&#x2013;991. doi: 10.1038/nn.4338.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4338</ArticleId><ArticleId IdType="pubmed">27459405</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke B.E., Patani R. The microglial component of amyotrophic lateral sclerosis. Brain. 2020;143:3526&#x2013;3539. doi: 10.1093/brain/awaa309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa309</ArticleId><ArticleId IdType="pmc">PMC7805793</ArticleId><ArticleId IdType="pubmed">33427296</ArticleId></ArticleIdList></Reference><Reference><Citation>Liddelow S.A., Barres B.A. Reactive astrocytes: Production, function, and therapeutic potential. Immunity. 2017;46:957&#x2013;967. doi: 10.1016/j.immuni.2017.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2017.06.006</ArticleId><ArticleId IdType="pubmed">28636962</ArticleId></ArticleIdList></Reference><Reference><Citation>Liddelow S.A., Guttenplan K.A., Clarke L.E., Bennett F.C., Bohlen C.J., Schirmer L., Bennett M.L., M&#xfc;nch A.E., Chung W.S., Peterson T.C., et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017;541:481&#x2013;487. doi: 10.1038/nature21029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature21029</ArticleId><ArticleId IdType="pmc">PMC5404890</ArticleId><ArticleId IdType="pubmed">28099414</ArticleId></ArticleIdList></Reference><Reference><Citation>Valori C.F., Guidotti G., Brambilla L., Rossi D. Astrocytes: Emerging therapeutic targets in neurological disorders. Trends Mol. Med. 2019;25:750&#x2013;759. doi: 10.1016/j.molmed.2019.04.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2019.04.010</ArticleId><ArticleId IdType="pubmed">31122805</ArticleId></ArticleIdList></Reference><Reference><Citation>McCauley M.E., Baloh R.H. Inflammation in ALS/FTD pathogenesis. Acta Neuropathol. 2019;137:715&#x2013;730. doi: 10.1007/s00401-018-1933-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1933-9</ArticleId><ArticleId IdType="pmc">PMC6482122</ArticleId><ArticleId IdType="pubmed">30465257</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper-Knock J., Hewitt C., Highley R., Brockington A., Milano A., Man S., Martindale J., Hartley J., Walsh T., Gelsthorpe C., et al. Clinico-pathological features in amyotrophic lateral sclerosis with expansions in C9ORF72. Brain. 2012;135:751&#x2013;764. doi: 10.1093/brain/awr365.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr365</ArticleId><ArticleId IdType="pmc">PMC3286332</ArticleId><ArticleId IdType="pubmed">22366792</ArticleId></ArticleIdList></Reference><Reference><Citation>Corcia P., Tauber C., Vercoullie J., Arlicot N., Prunier C., Praline J., Nicolas G., Venel Y., Hommet C., Baulieu J.-L., et al. Molecular imaging of microglial activation in amyotrophic lateral sclerosis. PLoS ONE. 2012;7:e52941. doi: 10.1371/journal.pone.0052941.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0052941</ArticleId><ArticleId IdType="pmc">PMC3534121</ArticleId><ArticleId IdType="pubmed">23300829</ArticleId></ArticleIdList></Reference><Reference><Citation>Engelhardt J.I., Appel S.H. IgG reactivity in the spinal cord and motor cortex in amyotrophic lateral sclerosis. Arch. Neurol. 1990;47:1210&#x2013;1216. doi: 10.1001/archneur.1990.00530110068019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.1990.00530110068019</ArticleId><ArticleId IdType="pubmed">2122877</ArticleId></ArticleIdList></Reference><Reference><Citation>Henkel J.S., Engelhardt J.I., Sikl&#xf3;s L., Simpson E.P., Kim S.H., Pan T., Goodman J.C., Siddique T., Beers D.R., Appel S.H. Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue. Ann. Neurol. 2003;55:221&#x2013;235. doi: 10.1002/ana.10805.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.10805</ArticleId><ArticleId IdType="pubmed">14755726</ArticleId></ArticleIdList></Reference><Reference><Citation>Nolan M., Scott C., Gamarallage M.P., Lunn D., Carpenter K., McDonough E., Meyer D., Kaanumalle S., Santamaria-Pang A., Turner M.R., et al. Quantitative patterns of motor cortex proteinopathy across ALS genotypes. Acta Neuropathol. Commun. 2020;8:1&#x2013;20. doi: 10.1186/s40478-020-00961-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-020-00961-2</ArticleId><ArticleId IdType="pmc">PMC7331195</ArticleId><ArticleId IdType="pubmed">32616036</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner M.R., Cagnin A., Turkheimer F.E., Miller C.C.J., Shaw C.E., Brooks D.J., Leigh P.N., Banati R.B. Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: An [11C](R)-PK11195 positron emission tomography study. Neurobiol. Dis. 2004;15:601&#x2013;609. doi: 10.1016/j.nbd.2003.12.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2003.12.012</ArticleId><ArticleId IdType="pubmed">15056468</ArticleId></ArticleIdList></Reference><Reference><Citation>Philips T., Rothstein J. Glial cells in amyotrophic lateral sclerosis. Exp. Neurol. 2014;262:111&#x2013;120. doi: 10.1016/j.expneurol.2014.05.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2014.05.015</ArticleId><ArticleId IdType="pmc">PMC4241182</ArticleId><ArticleId IdType="pubmed">24859452</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunter M., Spiller K.J., Dominique M.A., Xu H., Hunter F.W., Fang T.C., Canter R.G., Roberts C.J., Ransohoff R.M., Trojanowski J.Q., et al. Microglial transcriptome analysis in the rNLS8 mouse model of TDP-43 proteinopathy reveals discrete expression profiles associated with neurodegenerative progression and recovery. Acta Neuropathol. Commun. 2021;9:1&#x2013;19. doi: 10.1186/s40478-021-01239-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-021-01239-x</ArticleId><ArticleId IdType="pmc">PMC8377972</ArticleId><ArticleId IdType="pubmed">34412701</ArticleId></ArticleIdList></Reference><Reference><Citation>Jara J.H., Gautam M., Kocak N., Xie E.F., Mao Q., Bigio E.H., &#xd6;zdinler P.H. MCP1-CCR2 and neuroinflammation in the ALS motor cortex with TDP-43 pathology. J. Neuroinflamm. 2019;16:196. doi: 10.1186/s12974-019-1589-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-019-1589-y</ArticleId><ArticleId IdType="pmc">PMC6822373</ArticleId><ArticleId IdType="pubmed">31666087</ArticleId></ArticleIdList></Reference><Reference><Citation>Swarup V., Phaneuf D., Bareil C., Robertson J., Rouleau G.A., Kriz J., Julien J.-P. Pathological hallmarks of amyotrophic lateral sclerosis/frontotemporal lobar degeneration in transgenic mice produced with TDP-43 genomic fragments. Brain. 2011;134:2610&#x2013;2626. doi: 10.1093/brain/awr159.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr159</ArticleId><ArticleId IdType="pubmed">21752789</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong J., Huang C., Bi F., Wu Q., Huang B., Liu X., Li F., Zhou H., Xia X.-G. Expression of ALS-linked TDP-43 mutant in astrocytes causes non-cell-autonomous motor neuron death in rats. EMBO J. 2013;32:1917&#x2013;1926. doi: 10.1038/emboj.2013.122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2013.122</ArticleId><ArticleId IdType="pmc">PMC3981181</ArticleId><ArticleId IdType="pubmed">23714777</ArticleId></ArticleIdList></Reference><Reference><Citation>Wegorzewska I., Bell S., Cairns N.J., Miller T.M., Baloh R.H. TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Proc. Natl. Acad. Sci. USA. 2009;106:18809&#x2013;18814. doi: 10.1073/pnas.0908767106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0908767106</ArticleId><ArticleId IdType="pmc">PMC2762420</ArticleId><ArticleId IdType="pubmed">19833869</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y.-F., Zhang Y.-J., Lin W.-L., Cao X., Stetler C., Dickson D.W., Lewis J., Petrucelli L. Expression of mutant TDP-43 induces neuronal dysfunction in transgenic mice. Mol. Neurodegener. 2011;6:73. doi: 10.1186/1750-1326-6-73.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-6-73</ArticleId><ArticleId IdType="pmc">PMC3216869</ArticleId><ArticleId IdType="pubmed">22029574</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Tong J., Bi F., Wu Q., Huang B., Zhou H., Xia X.-G. Entorhinal cortical neurons are the primary targets of FUS mislocalization and ubiquitin aggregation in FUS transgenic rats. Hum. Mol. Genet. 2012;21:4602&#x2013;4614. doi: 10.1093/hmg/dds299.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/dds299</ArticleId><ArticleId IdType="pmc">PMC3471393</ArticleId><ArticleId IdType="pubmed">22833456</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Zhou H., Tong J., Chen H., Liu Y.-J., Wang D., Wei X., Xia X.-G. FUS transgenic rats develop the phenotypes of amyotrophic lateral sclerosis and frontotemporal lobar degeneration. PLoS Genet. 2011;7:e1002011. doi: 10.1371/journal.pgen.1002011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1002011</ArticleId><ArticleId IdType="pmc">PMC3048370</ArticleId><ArticleId IdType="pubmed">21408206</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirra A., Rossi S., Scaricamazza S., di Salvio M., Salvatori I., Valle C., Rusmini P., Poletti A., Cestra G., Carri M.T., et al. Functional interaction between FUS and SMN underlies SMA-like splicing changes in wild-type hFUS mice. Sci. Rep. 2017;7:1&#x2013;14. doi: 10.1038/s41598-017-02195-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-02195-0</ArticleId><ArticleId IdType="pmc">PMC5435706</ArticleId><ArticleId IdType="pubmed">28515487</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell J.C., McGoldrick P., Vance C., Hortobagyi T., Sreedharan J., Rogelj B., Tudor E.L., Smith B.N., Klasen C., Miller C.C., et al. Overexpression of human wild-type FUS causes progressive motor neuron degeneration in an age- and dose-dependent fashion. Acta Neuropathol. 2013;125:273&#x2013;288. doi: 10.1007/s00401-012-1043-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-012-1043-z</ArticleId><ArticleId IdType="pmc">PMC3549237</ArticleId><ArticleId IdType="pubmed">22961620</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma A., Lyashchenko A.K., Lu L., Nasrabady S.E., Elmaleh M., Mendelsohn M., Nemes A., Tapia J.C., Mentis G.Z., Shneider N.A. ALS-associated mutant FUS induces selective motor neuron degeneration through toxic gain of function. Nat. Commun. 2016;7:10465. doi: 10.1038/ncomms10465.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms10465</ArticleId><ArticleId IdType="pmc">PMC4742863</ArticleId><ArticleId IdType="pubmed">26842965</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J., van Deerlin V.M., Robinson J.L., Kwong L., Lee E.B., Ali Y.O., Safren N., Monteiro M.J., Toledo J., Elman L., et al. Pattern of ubiquilin pathology in ALS and FTLD indicates presence of C9ORF72 hexanucleotide expansion. Acta Neuropathol. 2012;123:825&#x2013;839. doi: 10.1007/s00401-012-0970-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-012-0970-z</ArticleId><ArticleId IdType="pmc">PMC3521561</ArticleId><ArticleId IdType="pubmed">22426854</ArticleId></ArticleIdList></Reference><Reference><Citation>Chew J., Gendron T.F., Prudencio M., Sasaguri H., Zhang Y.-J., Castanedes-Casey M., Lee C.W., Jansen-West K., Kurti A., Murray M.E., et al. C9ORF72 repeat expansions in mice cause TDP-43 pathology, neuronal loss, and behavioral deficits. Science. 2015;348:1151&#x2013;1154. doi: 10.1126/science.aaa9344.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaa9344</ArticleId><ArticleId IdType="pmc">PMC4692360</ArticleId><ArticleId IdType="pubmed">25977373</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Pattamatta A., Zu T., Reid T., Bardhi O., Borchelt D.R., Yachnis A.T., Ranum L.P.W. C9orf72 BAC mouse model with motor deficits and neurodegenerative features of ALS/FTD. Neuron. 2016;90:521&#x2013;534. doi: 10.1016/j.neuron.2016.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.04.005</ArticleId><ArticleId IdType="pubmed">27112499</ArticleId></ArticleIdList></Reference><Reference><Citation>Schludi M.H., Becker L., Garrett L., Gendron T.F., Zhou Q., Schreiber F., Popper B., Dimou L., Strom T.M., Winkelmann J., et al. Spinal poly-GA inclusions in a C9orf72 mouse model trigger motor deficits and inflammation without neuron loss. Acta Neuropathol. 2017;134:241&#x2013;254. doi: 10.1007/s00401-017-1711-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1711-0</ArticleId><ArticleId IdType="pmc">PMC5508040</ArticleId><ArticleId IdType="pubmed">28409281</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y.-J., Gendron T.F., Ebbert M.T.W., O&#x2019;Raw A., Yue M., Jansen-West K., Zhang X., Prudencio M., Chew J., Cook C.N., et al. Poly (GR) impairs protein translation and stress granule dynamics in C9orf72-associated frontotemporal dementia and amyotrophic lateral sclerosis. Nat. Med. 2018;24:1136&#x2013;1142. doi: 10.1038/s41591-018-0071-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-018-0071-1</ArticleId><ArticleId IdType="pmc">PMC6520050</ArticleId><ArticleId IdType="pubmed">29942091</ArticleId></ArticleIdList></Reference><Reference><Citation>LaClair K.D., Zhou Q., Michaelsen M., Wefers B., Brill M.S., Janjic A., Rathkolb B., Farny D., Cygan M., de Angelis M.H., et al. Congenic expression of poly-GA but not poly-PR in mice triggers selective neuron loss and interferon responses found in C9orf72 ALS. Acta Neuropathol. 2020;140:121&#x2013;142. doi: 10.1007/s00401-020-02176-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-020-02176-0</ArticleId><ArticleId IdType="pmc">PMC7360660</ArticleId><ArticleId IdType="pubmed">32562018</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J., Hyeon S.J., Im H., Ryu H., Kim Y., Ryu H. Astrocytes and microglia as non-cell autonomous players in the pathogenesis of ALS. Exp. Neurobiol. 2016;25:233&#x2013;240. doi: 10.5607/en.2016.25.5.233.</Citation><ArticleIdList><ArticleId IdType="doi">10.5607/en.2016.25.5.233</ArticleId><ArticleId IdType="pmc">PMC5081469</ArticleId><ArticleId IdType="pubmed">27790057</ArticleId></ArticleIdList></Reference><Reference><Citation>Haidet-Phillips A.M., Gross S.K., Williams T., Tuteja A., Sherman A., Ko M., Jeong Y.H., Wong P.C., Maragakis N.J. Altered astrocytic expression of TDP-43 does not influence motor neuron survival. Exp. Neurol. 2013;250:250&#x2013;259. doi: 10.1016/j.expneurol.2013.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2013.10.004</ArticleId><ArticleId IdType="pubmed">24120466</ArticleId></ArticleIdList></Reference><Reference><Citation>Serio A., Bilican B., Barmada S.J., Ando D.M., Zhao C., Siller R., Burr K., Haghi G., Story D., Nishimura A.L., et al. Astrocyte pathology and the absence of non-cell autonomy in an induced pluripotent stem cell model of TDP-43 proteinopathy. Proc. Natl. Acad. Sci. USA. 2013;110:4697&#x2013;4702. doi: 10.1073/pnas.1300398110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1300398110</ArticleId><ArticleId IdType="pmc">PMC3607024</ArticleId><ArticleId IdType="pubmed">23401527</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S., Kim S., Kang H.-Y., Lim H.R., Kwon Y., Jo M., Jeon Y.-M., Kim S.R., Kim K., Ha C.M., et al. The overexpression of TDP-43 in astrocytes causes neurodegeneration via a PTP1B-mediated inflammatory response. J. Neuroinflamm. 2020;17:1&#x2013;22. doi: 10.1186/s12974-020-01963-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-020-01963-6</ArticleId><ArticleId IdType="pmc">PMC7556969</ArticleId><ArticleId IdType="pubmed">33054766</ArticleId></ArticleIdList></Reference><Reference><Citation>Birger A., Ben-Dor I., Ottolenghi M., Turetsky T., Gil Y., Sweetat S., Perez L., Belzer V., Casden N., Steiner D., et al. Human iPSC-derived astrocytes from ALS patients with mutated C9ORF72 show increased oxidative stress and neurotoxicity. EBioMedicine. 2019;50:274&#x2013;289. doi: 10.1016/j.ebiom.2019.11.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2019.11.026</ArticleId><ArticleId IdType="pmc">PMC6921360</ArticleId><ArticleId IdType="pubmed">31787569</ArticleId></ArticleIdList></Reference><Reference><Citation>Haidet-Phillips A.M., Hester M.E., Miranda C., Meyer K., Braun L., Frakes A., Song S., Likhite S., Murtha M.J., Foust K.D., et al. Astrocytes from familial and sporadic ALS patients are toxic to motor neurons. Nat. Biotechnol. 2011;29:824&#x2013;828. doi: 10.1038/nbt.1957.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.1957</ArticleId><ArticleId IdType="pmc">PMC3170425</ArticleId><ArticleId IdType="pubmed">21832997</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer K., Ferraiuolo L., Miranda C.J., Likhite S., McElroy S., Renusch S., Ditsworth D., Lagier-Tourenne C., Smith R.A., Ravits J., et al. Direct conversion of patient fibroblasts demonstrates non-cell autonomous toxicity of astrocytes to motor neurons in familial and sporadic ALS. Proc. Natl. Acad. Sci. USA. 2014;111:829&#x2013;832. doi: 10.1073/pnas.1314085111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1314085111</ArticleId><ArticleId IdType="pmc">PMC3896192</ArticleId><ArticleId IdType="pubmed">24379375</ArticleId></ArticleIdList></Reference><Reference><Citation>Qian K., Huang H., Peterson A., Hu B., Maragakis N.J., Ming G.-L., Chen H., Zhang S.-C. Sporadic ALS astrocytes induce neuronal degeneration in vivo. Stem Cell Rep. 2017;8:843&#x2013;855. doi: 10.1016/j.stemcr.2017.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2017.03.003</ArticleId><ArticleId IdType="pmc">PMC5390239</ArticleId><ArticleId IdType="pubmed">28366455</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao C., Devlin A., Chouhan A.K., Selvaraj B.T., Stavrou M., Burr K., Brivio V., He X., Mehta A.R., Story D., et al. Mutant C9orf72 human iPSC-derived astrocytes cause non-cell autonomous motor neuron pathophysiology. Glia. 2019;68:1046&#x2013;1064. doi: 10.1002/glia.23761.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23761</ArticleId><ArticleId IdType="pmc">PMC7078830</ArticleId><ArticleId IdType="pubmed">31841614</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu L., Zheng L., Si Y., Luo W., Dujardin G., Kwan T., Potochick N.R., Thompson S., Schneider D., King P.H. Hu antigen R (HuR) is a positive regulator of the RNA-binding proteins TDP-43 and FUS/TLS. J. Biol. Chem. 2014;289:31792&#x2013;31804. doi: 10.1074/jbc.M114.573246.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M114.573246</ArticleId><ArticleId IdType="pmc">PMC4231657</ArticleId><ArticleId IdType="pubmed">25239623</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas F., Cortes N., Abarzua S., Dyrda A., van Zundert B.A. Astrocytes expressing mutant SOD1 and TDP43 trigger motoneuron death that is mediated via sodium channels and nitroxidative stress. Front. Cell. Neurosci. 2014;8:24. doi: 10.3389/fncel.2014.00024.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2014.00024</ArticleId><ArticleId IdType="pmc">PMC3916762</ArticleId><ArticleId IdType="pubmed">24570655</ArticleId></ArticleIdList></Reference><Reference><Citation>Kia A., McAvoy K., Krishnamurthy K., Trotti D., Pasinelli P. Astrocytes expressing ALS-linked mutant FUS induce motor neuron death through release of tumor necrosis factor-alpha. Glia. 2018;66:1016&#x2013;1033. doi: 10.1002/glia.23298.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23298</ArticleId><ArticleId IdType="pmc">PMC5873384</ArticleId><ArticleId IdType="pubmed">29380416</ArticleId></ArticleIdList></Reference><Reference><Citation>Madill M., McDonagh K., Ma J., Vajda A., McLoughlin P., O&#x2019;Brien T., Hardiman O., Shen S. Amyotrophic lateral sclerosis patient iPSC-derived astrocytes impair autophagy via non-cell autonomous mechanisms. Mol. Brain. 2017;10:1&#x2013;12. doi: 10.1186/s13041-017-0300-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-017-0300-4</ArticleId><ArticleId IdType="pmc">PMC5470320</ArticleId><ArticleId IdType="pubmed">28610619</ArticleId></ArticleIdList></Reference><Reference><Citation>Ajmone-Cat M.A., Onori A., Toselli C., Stronati E., Morlando M., Bozzoni I., Monni E., Kokaia Z., Lupo G., Minghetti L., et al. Increased FUS levels in astrocytes leads to astrocyte and microglia activation and neuronal death. Sci. Rep. 2019;9:4572. doi: 10.1038/s41598-019-41040-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-41040-4</ArticleId><ArticleId IdType="pmc">PMC6418113</ArticleId><ArticleId IdType="pubmed">30872738</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabatelli M., Moncada A., Conte A., Lattante S., Marangi G., Luigetti M., Lucchini M., Mirabella M., Romano A., del Grande A., et al. Mutations in the 3&#x2032; untranslated region of FUS causing FUS overexpression are associated with amyotrophic lateral sclerosis. Hum. Mol. Genet. 2013;22:4748&#x2013;4755. doi: 10.1093/hmg/ddt328.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt328</ArticleId><ArticleId IdType="pubmed">23847048</ArticleId></ArticleIdList></Reference><Reference><Citation>Modigliani S.D., Morlando M., Errichelli L., Sabatelli M., Bozzoni I. An ALS-associated mutation in the FUS 3&#x2032;-UTR disrupts a microRNA&#x2013;FUS regulatory circuitry. Nat. Commun. 2014;5:4335. doi: 10.1038/ncomms5335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms5335</ArticleId><ArticleId IdType="pubmed">25004804</ArticleId></ArticleIdList></Reference><Reference><Citation>Aebischer J., Bernard-Marissal N., Pettmann B., Raoul C. Death receptors in the selective degeneration of motoneurons in amyotrophic lateral sclerosis. J. Neurodegener. Dis. 2013;2013:746845. doi: 10.1155/2013/746845.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/746845</ArticleId><ArticleId IdType="pmc">PMC4437334</ArticleId><ArticleId IdType="pubmed">26316997</ArticleId></ArticleIdList></Reference><Reference><Citation>Correia A.S., Patel P., Dutta K., Julien J.-P. Inflammation induces TDP-43 mislocalization and aggregation. PLoS ONE. 2015;10:e0140248. doi: 10.1371/journal.pone.0140248.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0140248</ArticleId><ArticleId IdType="pmc">PMC4596857</ArticleId><ArticleId IdType="pubmed">26444430</ArticleId></ArticleIdList></Reference><Reference><Citation>Herman A.M., Khandelwal P.J., Rebeck G.W., Moussa C.E.-H. Wild type TDP-43 induces neuro-inflammation and alters APP metabolism in lentiviral gene transfer models. Exp. Neurol. 2012;235:297&#x2013;305. doi: 10.1016/j.expneurol.2012.02.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2012.02.011</ArticleId><ArticleId IdType="pmc">PMC3434705</ArticleId><ArticleId IdType="pubmed">22402344</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W., Beers D.R., Bell S., Wang J., Wen S., Baloh R.H., Appel S.H. TDP-43 activates microglia through NF-&#x3ba;B and NLRP3 inflammasome. Exp. Neurol. 2015;273:24&#x2013;35. doi: 10.1016/j.expneurol.2015.07.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2015.07.019</ArticleId><ArticleId IdType="pubmed">26222336</ArticleId></ArticleIdList></Reference><Reference><Citation>Smethurst P., Risse E., Tyzack G.E., Mitchell J.S., Taha D.M., Chen Y.-R., Newcombe J., Collinge J., Sidle K., Patani R. Distinct responses of neurons and astrocytes to TDP-43 proteinopathy in amyotrophic lateral sclerosis. Brain. 2020;143:430&#x2013;440. doi: 10.1093/brain/awz419.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz419</ArticleId><ArticleId IdType="pmc">PMC7009461</ArticleId><ArticleId IdType="pubmed">32040555</ArticleId></ArticleIdList></Reference><Reference><Citation>Fomin V., Richard P., Hoque M., Li C., Gu Z., Fissore-O&#x2019;Leary M., Tian B., Prives C., Manley J.L. The C9ORF72 gene, implicated in amyotrophic lateral sclerosis and frontotemporal dementia, encodes a protein that functions in control of endothelin and glutamate signaling. Mol. Cell. Biol. 2018;38:e00155-18. doi: 10.1128/MCB.00155-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.00155-18</ArticleId><ArticleId IdType="pmc">PMC6206455</ArticleId><ArticleId IdType="pubmed">30150298</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothstein J.D., Martin L., Levey A.I., Dykes-Hoberg M., Jin L., Wu D., Nash N., Kuncl R.W. Localization of neuronal and glial glutamate transporters. Neuron. 1994;13:713&#x2013;725. doi: 10.1016/0896-6273(94)90038-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0896-6273(94)90038-8</ArticleId><ArticleId IdType="pubmed">7917301</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothstein J.D., Dykes-Hoberg M., Pardo C.A., Bristol L.A., Jin L., Kuncl R.W., Kanai Y., Hediger M.A., Wang Y., Schielke J.P., et al. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron. 1996;16:675&#x2013;686. doi: 10.1016/S0896-6273(00)80086-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(00)80086-0</ArticleId><ArticleId IdType="pubmed">8785064</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaper D., Adachi Y., Lazarou L., Greenstein M., Simoes F., di Domenico A., Solomon D.A., Lowe S., Alsubaie R., Cheng D., et al. Drosophila TDP-43 dysfunction in glia and muscle cells cause cytological and behavioural phenotypes that characterize ALS and FTLD. Hum. Mol. Genet. 2013;22:3883&#x2013;3893. doi: 10.1093/hmg/ddt243.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt243</ArticleId><ArticleId IdType="pmc">PMC3766182</ArticleId><ArticleId IdType="pubmed">23727833</ArticleId></ArticleIdList></Reference><Reference><Citation>Estes P.S., Daniel S., Mccallum A.P., Boehringer A.V., Sukhina A.S., Zwick R.A., Zarnescu D.C. Motor neurons and glia exhibit specific individualized responses to TDP-43 expression in a drosophila model of amyotrophic lateral sclerosis. Dis. Model. Mech. 2013;6:721&#x2013;733. doi: 10.1242/dmm.010710.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.010710</ArticleId><ArticleId IdType="pmc">PMC3634655</ArticleId><ArticleId IdType="pubmed">23471911</ArticleId></ArticleIdList></Reference><Reference><Citation>Cragnaz L., Klima R., de Conti L., Romano G., Feiguin F., Buratti E., Baralle M., Baralle F. An age-related reduction of brain TBPH/TDP-43 levels precedes the onset of locomotion defects in a drosophila ALS model. Neuroscience. 2015;311:415&#x2013;421. doi: 10.1016/j.neuroscience.2015.10.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2015.10.037</ArticleId><ArticleId IdType="pubmed">26518462</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng A.Y.T., Agrawal I., Ho W.Y., Yen Y.-C., Pinter A.J., Liu J., Phua Q.X.C., Koh K.B., Chang J.-C., Sanford E., et al. Loss of TDP-43 in astrocytes leads to motor deficits by triggering A1-like reactive phenotype and triglial dysfunction. Proc. Natl. Acad. Sci. USA. 2020;117:29101&#x2013;29112. doi: 10.1073/pnas.2007806117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2007806117</ArticleId><ArticleId IdType="pmc">PMC7682406</ArticleId><ArticleId IdType="pubmed">33127758</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwiatkowski T.J., Jr., Bosco D.A., Leclerc A.L., Tamrazian E., Vanderburg C.R., Russ C., Davis A., Gilchrist J., Kasarskis E.J., Munsat T., et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science. 2009;323:1205&#x2013;1208. doi: 10.1126/science.1166066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1166066</ArticleId><ArticleId IdType="pubmed">19251627</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreedharan J., Blair I.P., Tripathi V.B., Hu X., Vance C., Rogelj B., Ackerley S., Durnall J.C., Williams K.L., Buratti E., et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science. 2008;319:1668&#x2013;1672. doi: 10.1126/science.1154584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1154584</ArticleId><ArticleId IdType="pmc">PMC7116650</ArticleId><ArticleId IdType="pubmed">18309045</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C., Rogelj B., Hortob&#xe1;gyi T., de Vos K.J., Nishimura A.L., Sreedharan J., Hu X., Smith B., Ruddy D., Wright P., et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science. 2009;323:1208&#x2013;1211. doi: 10.1126/science.1165942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1165942</ArticleId><ArticleId IdType="pmc">PMC4516382</ArticleId><ArticleId IdType="pubmed">19251628</ArticleId></ArticleIdList></Reference><Reference><Citation>Birsa N., Bentham M.P., Fratta P. Cytoplasmic functions of TDP-43 and FUS and their role in ALS. Semin. Cell Dev. Biol. 2020;99:193&#x2013;201. doi: 10.1016/j.semcdb.2019.05.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcdb.2019.05.023</ArticleId><ArticleId IdType="pubmed">31132467</ArticleId></ArticleIdList></Reference><Reference><Citation>Ederle H., Dormann D. TDP-43 and FUS en route from the nucleus to the cytoplasm. FEBS Lett. 2017;591:1489&#x2013;1507. doi: 10.1002/1873-3468.12646.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1873-3468.12646</ArticleId><ArticleId IdType="pubmed">28380257</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishihira Y., Tan C.-F., Onodera O., Toyoshima Y., Yamada M., Morita T., Nishizawa M., Kakita A., Takahashi H. Sporadic amyotrophic lateral sclerosis: Two pathological patterns shown by analysis of distribution of TDP-43-immunoreactive neuronal and glial cytoplasmic inclusions. Acta Neuropathol. 2008;116:169&#x2013;182. doi: 10.1007/s00401-008-0385-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-008-0385-z</ArticleId><ArticleId IdType="pubmed">18481073</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H., Tan C.-F., Mori F., Tanji K., Kakita A., Takahashi H., Wakabayashi K. TDP-43-immunoreactive neuronal and glial inclusions in the neostriatum in amyotrophic lateral sclerosis with and without dementia. Acta Neuropathol. 2007;115:115&#x2013;122. doi: 10.1007/s00401-007-0285-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-007-0285-7</ArticleId><ArticleId IdType="pubmed">17786458</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai T., Hasegawa M., Akiyama H., Ikeda K., Nonaka T., Mori H., Mann D., Tsuchiya K., Yoshida M., Hashizume Y., et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 2006;351:602&#x2013;611. doi: 10.1016/j.bbrc.2006.10.093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2006.10.093</ArticleId><ArticleId IdType="pubmed">17084815</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M., et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130&#x2013;133. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Romano G., Appocher C., Scorzeto M., Klima R., Baralle F.E., Megighian A., Feiguin F. Glial TDP-43 regulates axon wrapping, GluRIIA clustering and fly motility by autonomous and non-autonomous mechanisms. Hum. Mol. Genet. 2015;24:6134&#x2013;6145. doi: 10.1093/hmg/ddv330.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddv330</ArticleId><ArticleId IdType="pmc">PMC4599672</ArticleId><ArticleId IdType="pubmed">26276811</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalfallah Y., Kuta R., Grasmuck C., Prat A., Durham H.D., Velde C.V. TDP-43 regulation of stress granule dynamics in neurodegenerative disease-relevant cell types. Sci. Rep. 2018;8:7551. doi: 10.1038/s41598-018-25767-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-25767-0</ArticleId><ArticleId IdType="pmc">PMC5953947</ArticleId><ArticleId IdType="pubmed">29765078</ArticleId></ArticleIdList></Reference><Reference><Citation>Moujalled D., Grubman A., Acevedo K., Yang S., Ke Y., Moujalled D.M., Duncan C., Caragounis A., Perera N.D., Turner B., et al. TDP-43 mutations causing amyotrophic lateral sclerosis are associated with altered expression of RNA-binding protein hnRNP K and affect the Nrf2 antioxidant pathway. Hum. Mol. Genet. 2017;26:1732&#x2013;1746. doi: 10.1093/hmg/ddx093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddx093</ArticleId><ArticleId IdType="pubmed">28334913</ArticleId></ArticleIdList></Reference><Reference><Citation>Barton S.K., Lau C.L., Chiam M.D.F., Tomas D., Muyderman H., Beart P.M., Turner B.J. Mutant TDP-43 expression triggers TDP-43 pathology and cell autonomous effects on primary astrocytes: Implications for non-cell autonomous pathology in ALS. Neurochem. Res. 2020;45:1451&#x2013;1459. doi: 10.1007/s11064-020-03048-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-020-03048-5</ArticleId><ArticleId IdType="pubmed">32410044</ArticleId></ArticleIdList></Reference><Reference><Citation>Velebit J., Horvat A., Smoli&#x10d; T., Mihevc S.P., Rogelj B., Zorec R., Vardjan N. Astrocytes with TDP-43 inclusions exhibit reduced noradrenergic cAMP and Ca 2+ signaling and dysregulated cell metabolism. Sci. Rep. 2020;10:1&#x2013;18. doi: 10.1038/s41598-020-62864-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-62864-5</ArticleId><ArticleId IdType="pmc">PMC7138839</ArticleId><ArticleId IdType="pubmed">32265469</ArticleId></ArticleIdList></Reference><Reference><Citation>Swarup V., Phaneuf D., Dupr&#xe9; N., Petri S., Strong M., Kriz J., Julien J.-P. Deregulation of TDP-43 in amyotrophic lateral sclerosis triggers nuclear factor &#x3ba;B&#x2013;mediated pathogenic pathways. J. Exp. Med. 2011;208:2429&#x2013;2447. doi: 10.1084/jem.20111313.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20111313</ArticleId><ArticleId IdType="pmc">PMC3256969</ArticleId><ArticleId IdType="pubmed">22084410</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia Q., Hu Q., Wang H., Yang H., Gao F., Ren H., Chen D., Fu C., Zheng L., Zhen X., et al. Induction of COX-2-PGE2 synthesis by activation of the MAPK/ERK pathway contributes to neuronal death triggered by TDP-43-depleted microglia. Cell Death Dis. 2015;6:e1702. doi: 10.1038/cddis.2015.69.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2015.69</ArticleId><ArticleId IdType="pmc">PMC4385945</ArticleId><ArticleId IdType="pubmed">25811799</ArticleId></ArticleIdList></Reference><Reference><Citation>LaRocca T.J., Mariani A., Watkins L.R., Link C.D. TDP-43 knockdown causes innate immune activation via protein kinase R in astrocytes. Neurobiol. Dis. 2019;132:104514. doi: 10.1016/j.nbd.2019.104514.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2019.104514</ArticleId><ArticleId IdType="pmc">PMC6834892</ArticleId><ArticleId IdType="pubmed">31229690</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasai T., Tokuda T., Ishigami N., Sasayama H., Foulds P., Mitchell D.J., Mann D.M.A., Allsop D., Nakagawa M. Increased TDP-43 protein in cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Acta Neuropathol. 2009;117:55&#x2013;62. doi: 10.1007/s00401-008-0456-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-008-0456-1</ArticleId><ArticleId IdType="pubmed">18989684</ArticleId></ArticleIdList></Reference><Reference><Citation>Noto Y.-I., Shibuya K., Sato Y., Kanai K., Misawa S., Sawai S., Mori M., Uchiyama T., Isose S., Nasu S., et al. Elevated CSF TDP-43 levels in amyotrophic lateral sclerosis: Specificity, sensitivity, and a possible prognostic value. Amyotroph. Lateral Scler. 2010;12:140&#x2013;143. doi: 10.3109/17482968.2010.541263.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2010.541263</ArticleId><ArticleId IdType="pubmed">21126161</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinacker P., Hendrich C., Sperfeld A.D., Jesse S., von Arnim C.A.F., Lehnert S., Pabst A., Uttner I., Tumani H., Lee V.M.-Y., et al. TDP-43 in cerebrospinal fluid of patients with frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Arch. Neurol. 2008;65:1481&#x2013;1487. doi: 10.1001/archneur.65.11.1481.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.65.11.1481</ArticleId><ArticleId IdType="pmc">PMC2690860</ArticleId><ArticleId IdType="pubmed">19001167</ArticleId></ArticleIdList></Reference><Reference><Citation>Smethurst P., Sidle K.C.L., Hardy J. Review: Prion-like mechanisms of transactive response DNA binding protein of 43 kDa (TDP-43) in amyotrophic lateral sclerosis (ALS) Neuropathol. Appl. Neurobiol. 2014;41:578&#x2013;597. doi: 10.1111/nan.12206.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12206</ArticleId><ArticleId IdType="pubmed">25487060</ArticleId></ArticleIdList></Reference><Reference><Citation>Leal-Lasarte M.M., Franco J.M., Labrador-Garrido A., Pozo D., Roodveldt C. Extracellular TDP-43 aggregates target MAPK/MAK/MRK overlapping kinase (MOK) and trigger caspase-3/IL-18 signaling in microglia. FASEB J. 2017;31:2797&#x2013;2816. doi: 10.1096/fj.201601163R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201601163R</ArticleId><ArticleId IdType="pubmed">28336525</ArticleId></ArticleIdList></Reference><Reference><Citation>Smeyers J., Banchi E.-G., Latouche M. C9ORF72: What it is, what it does, and why it matters. Front. Cell. Neurosci. 2021;15:661447. doi: 10.3389/fncel.2021.661447.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2021.661447</ArticleId><ArticleId IdType="pmc">PMC8131521</ArticleId><ArticleId IdType="pubmed">34025358</ArticleId></ArticleIdList></Reference><Reference><Citation>Farg M.A., Sundaramoorthy V., Sultana J.M., Yang S., Atkinson R., Levina V., Halloran M.A., Gleeson P., Blair I., Soo K.Y., et al. C9ORF72, implicated in amytrophic lateral sclerosis and frontotemporal dementia, regulates endosomal trafficking. Hum. Mol. Genet. 2014;23:3579&#x2013;3595. doi: 10.1093/hmg/ddu068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu068</ArticleId><ArticleId IdType="pmc">PMC4049310</ArticleId><ArticleId IdType="pubmed">24549040</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine T.P., Daniels R.D., Gatta A.T., Wong L.H., Hayes M.J. The product of C9orf72, a gene strongly implicated in neurodegeneration, is structurally related to DENN Rab-GEFs. Bioinformatics. 2013;29:499&#x2013;503. doi: 10.1093/bioinformatics/bts725.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bts725</ArticleId><ArticleId IdType="pmc">PMC3570213</ArticleId><ArticleId IdType="pubmed">23329412</ArticleId></ArticleIdList></Reference><Reference><Citation>Sellier C., Campanari M., Corbier C.J., Gaucherot A., Kolb-Cheynel I., Oulad-Abdelghani M., Ruffenach F., Page A., Ciura S., Kabashi E., et al. Loss of C9 ORF 72 impairs autophagy and synergizes with polyQ Ataxin-2 to induce motor neuron dysfunction and cell death. EMBO J. 2016;35:1276&#x2013;1297. doi: 10.15252/embj.201593350.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201593350</ArticleId><ArticleId IdType="pmc">PMC4910533</ArticleId><ArticleId IdType="pubmed">27103069</ArticleId></ArticleIdList></Reference><Reference><Citation>Sullivan P.M., Zhou X., Robins A.M., Paushter D.H., Kim D., Smolka M.B., Hu F. The ALS/FTLD associated protein C9orf72 associates with SMCR8 and WDR41 to regulate the autophagy-lysosome pathway. Acta Neuropathol. Commun. 2016;4:51. doi: 10.1186/s40478-016-0324-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-016-0324-5</ArticleId><ArticleId IdType="pmc">PMC4870812</ArticleId><ArticleId IdType="pubmed">27193190</ArticleId></ArticleIdList></Reference><Reference><Citation>Webster C.P., Smith E.F., Bauer C.S., Moller A., Hautbergue G.M., Ferraiuolo L., Myszczynska M., Higginbottom A., Walsh M.J., Whitworth A.J., et al. The C9orf72 protein interacts with Rab1a and the ULK 1 complex to regulate initiation of autophagy. EMBO J. 2016;35:1656&#x2013;1676. doi: 10.15252/embj.201694401.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201694401</ArticleId><ArticleId IdType="pmc">PMC4969571</ArticleId><ArticleId IdType="pubmed">27334615</ArticleId></ArticleIdList></Reference><Reference><Citation>Webster C.P., Smith E.F., Grierson A.J., de Vos K.J. C9orf72 plays a central role in Rab GTPase-dependent regulation of autophagy. Small GTPases. 2018;9:399&#x2013;408. doi: 10.1080/21541248.2016.1240495.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21541248.2016.1240495</ArticleId><ArticleId IdType="pmc">PMC5997165</ArticleId><ArticleId IdType="pubmed">27768524</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang M., Liang C., Swaminathan K., Herrlinger S., Lai F., Shiekhattar R., Chen J.-F. A C9ORF72/SMCR8-containing complex regulates ULK1 and plays a dual role in autophagy. Sci. Adv. 2016;2:e1601167. doi: 10.1126/sciadv.1601167.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.1601167</ArticleId><ArticleId IdType="pmc">PMC5010369</ArticleId><ArticleId IdType="pubmed">27617292</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang D., Iyer L.M., He F., Aravind L. Discovery of novel DENN proteins: Implications for the evolution of eukaryotic intracellular membrane structures and human disease. Front. Genet. 2012;3:283. doi: 10.3389/fgene.2012.00283.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2012.00283</ArticleId><ArticleId IdType="pmc">PMC3521125</ArticleId><ArticleId IdType="pubmed">23248642</ArticleId></ArticleIdList></Reference><Reference><Citation>Atanasio A., Decman V., White D., Ramos M., Ikiz B., Lee H.-C., Siao C.-J., Brydges S., LaRosa E., Bai Y., et al. C9orf72 ablation causes immune dysregulation characterized by leukocyte expansion, autoantibody production and glomerulonephropathy in mice. Sci. Rep. 2016;6:23204. doi: 10.1038/srep23204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep23204</ArticleId><ArticleId IdType="pmc">PMC4793236</ArticleId><ArticleId IdType="pubmed">26979938</ArticleId></ArticleIdList></Reference><Reference><Citation>Burberry A., Suzuki N., Wang J.-Y., Moccia R., Mordes D.A., Stewart M.H., Suzuki-Uematsu S., Ghosh S., Singh A., Merkle F.T., et al. Loss-of-function mutations in the C9ORF72 mouse ortholog cause fatal autoimmune disease. Sci. Transl. Med. 2016;8:347ra93. doi: 10.1126/scitranslmed.aaf6038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aaf6038</ArticleId><ArticleId IdType="pmc">PMC5024536</ArticleId><ArticleId IdType="pubmed">27412785</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Rourke J.G., Bogdanik L., Y&#xe1;&#xf1;ez A., Lall D., Wolf A.J., Muhammad A.K.M.G., Ho R., Carmona S., Vit J.P., Zarrow J., et al. C9orf72 is required for proper macrophage and microglial function in mice. Science. 2016;351:1324&#x2013;1329. doi: 10.1126/science.aaf1064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf1064</ArticleId><ArticleId IdType="pmc">PMC5120541</ArticleId><ArticleId IdType="pubmed">26989253</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Rourke J.G., Bogdanik L., Muhammad A., Gendron T.F., Kim K.J., Austin A., Cady J., Liu E.Y., Zarrow J., Grant S., et al. C9orf72 BAC transgenic mice display typical pathologic features of ALS/FTD. Neuron. 2015;88:892&#x2013;901. doi: 10.1016/j.neuron.2015.10.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2015.10.027</ArticleId><ArticleId IdType="pmc">PMC4672384</ArticleId><ArticleId IdType="pubmed">26637796</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters O., Cabrera G.T., Tran H., Gendron T.F., McKeon J.E., Metterville J., Weiss A., Wightman N., Salameh J., Kim J., et al. Human C9ORF72 hexanucleotide expansion reproduces RNA foci and dipeptide repeat proteins but not neurodegeneration in BAC transgenic mice. Neuron. 2015;88:902&#x2013;909. doi: 10.1016/j.neuron.2015.11.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2015.11.018</ArticleId><ArticleId IdType="pmc">PMC4828340</ArticleId><ArticleId IdType="pubmed">26637797</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y., Lin S., Staats K.A., Li Y., Chang W.-H., Hung S.-T., Hendricks E., Linares G.R., Wang Y., Son E.Y., et al. Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neurons. Nat. Med. 2018;24:313&#x2013;325. doi: 10.1038/nm.4490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4490</ArticleId><ArticleId IdType="pmc">PMC6112156</ArticleId><ArticleId IdType="pubmed">29400714</ArticleId></ArticleIdList></Reference><Reference><Citation>Langseth A., Kim J., Ugolino J.E., Shah Y., Hwang H.-Y., Wang J., Bergles D.E., Brown S.P. Cell-type specific differences in promoter activity of the ALS-linked C9orf72 mouse ortholog. Sci. Rep. 2017;7:1&#x2013;13. doi: 10.1038/s41598-017-05864-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-05864-2</ArticleId><ArticleId IdType="pmc">PMC5515847</ArticleId><ArticleId IdType="pubmed">28720882</ArticleId></ArticleIdList></Reference><Reference><Citation>Braems E., Swinnen B., Bosch L.V.D. C9orf72 loss-of-function: A trivial, stand-alone or additive mechanism in C9 ALS/FTD? Acta Neuropathol. 2020;140:625&#x2013;643. doi: 10.1007/s00401-020-02214-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-020-02214-x</ArticleId><ArticleId IdType="pmc">PMC7547039</ArticleId><ArticleId IdType="pubmed">32876811</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Sarraj S., King A., Troakes C., Smith B., Maekawa S., Bodi I., Rogelj B., Al-Chalabi A., Hortob&#xe1;gyi T., Shaw C.E. P62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS. Acta Neuropathol. 2011;122:691&#x2013;702. doi: 10.1007/s00401-011-0911-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-011-0911-2</ArticleId><ArticleId IdType="pubmed">22101323</ArticleId></ArticleIdList></Reference><Reference><Citation>Balendra R., Isaacs A.M. C9orf72-mediated ALS and FTD: Multiple pathways to disease. Nat. Rev. Neurol. 2018;14:544&#x2013;558. doi: 10.1038/s41582-018-0047-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-018-0047-2</ArticleId><ArticleId IdType="pmc">PMC6417666</ArticleId><ArticleId IdType="pubmed">30120348</ArticleId></ArticleIdList></Reference><Reference><Citation>Rostalski H., Leskel&#xe4; S., Huber N., Katisko K., Cajanus A., Solje E., Marttinen M., Natunen T., Remes A.M., Hiltunen M., et al. Astrocytes and microglia as potential contributors to the pathogenesis of C9orf72 repeat expansion-associated FTLD and ALS. Front. Neurosci. 2019;13:486. doi: 10.3389/fnins.2019.00486.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00486</ArticleId><ArticleId IdType="pmc">PMC6529740</ArticleId><ArticleId IdType="pubmed">31156371</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper-Knock J., Walsh M.J., Higginbottom A., Highley R., Dickman M., Edbauer D., Ince P.G., Wharton S.B., Wilson S., Kirby J., et al. Sequestration of multiple RNA recognition motif-containing proteins by C9orf72 repeat expansions. Brain. 2014;137:2040&#x2013;2051. doi: 10.1093/brain/awu120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awu120</ArticleId><ArticleId IdType="pmc">PMC4065024</ArticleId><ArticleId IdType="pubmed">24866055</ArticleId></ArticleIdList></Reference><Reference><Citation>Donnelly C.J., Zhang P.-W., Pham J.T., Haeusler A.R., Mistry N.A., Vidensky S., Daley E., Poth E.M., Hoover B., Fines D.M., et al. RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention. Neuron. 2013;80:415&#x2013;428. doi: 10.1016/j.neuron.2013.10.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.10.015</ArticleId><ArticleId IdType="pmc">PMC4098943</ArticleId><ArticleId IdType="pubmed">24139042</ArticleId></ArticleIdList></Reference><Reference><Citation>Hautbergue G.M., Castelli L.M., Ferraiuolo L., Sanchez-Martinez A., Cooper-Knock J., Higginbottom A., Lin Y.-H., Bauer C.S., Dodd J.E., Myszczynska M., et al. SRSF1-dependent nuclear export inhibition of C9ORF72 repeat transcripts prevents neurodegeneration and associated motor deficits. Nat. Commun. 2017;8:16063. doi: 10.1038/ncomms16063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms16063</ArticleId><ArticleId IdType="pmc">PMC5504286</ArticleId><ArticleId IdType="pubmed">28677678</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori K., Lammich S., MacKenzie I.R.A., Forn&#xe9; I., Zilow S., Kretzschmar H., Edbauer D., Janssens J., Kleinberger G., Cruts M., et al. HnRNP A3 binds to GGGGCC repeats and is a constituent of p62-positive/TDP43-negative inclusions in the hippocampus of patients with C9orf72 mutations. Acta Neuropathol. 2013;125:413&#x2013;423. doi: 10.1007/s00401-013-1088-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1088-7</ArticleId><ArticleId IdType="pubmed">23381195</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramesh N., Daley E.L., Gleixner A.M., Mann J.R., Kour S., Mawrie D., Anderson E.N., Kofler J., Donnelly C.J., Kiskinis E., et al. RNA dependent suppression of C9orf72 ALS/FTD associated neurodegeneration by matrin-3. Acta Neuropathol. Commun. 2020;8:1&#x2013;20. doi: 10.1186/s40478-020-01060-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-020-01060-y</ArticleId><ArticleId IdType="pmc">PMC7603783</ArticleId><ArticleId IdType="pubmed">33129345</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi S., Serrano A., Gerbino V., Giorgi A., di Francesco L., Nencini M., Bozzo F., Schinin&#xe0; M.E., Bagni C., Cestra G., et al. Nuclear accumulation of mRNAs underlies G4C2 repeat-induced translational repression in a cellular model of C9orf72 ALS. J. Cell Sci. 2015;128:1787&#x2013;1799. doi: 10.1242/jcs.165332.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.165332</ArticleId><ArticleId IdType="pubmed">25788698</ArticleId></ArticleIdList></Reference><Reference><Citation>Sareen D., O&#x2019;Rourke J.G., Meera P., Muhammad A.K.M.G., Grant S., Simpkinson M., Bell S., Carmona S., Ornelas L., Sahabian A., et al. Targeting RNA foci in iPSC-derived motor neurons from ALS patients with a C9ORF72 repeat expansion. Sci. Transl. Med. 2013;5:208ra149. doi: 10.1126/scitranslmed.3007529.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.3007529</ArticleId><ArticleId IdType="pmc">PMC4090945</ArticleId><ArticleId IdType="pubmed">24154603</ArticleId></ArticleIdList></Reference><Reference><Citation>Conlon E.G., Lu L., Sharma A., Yamazaki T., Tang T., Shneider N.A., Manley J.L. The C9ORF72 GGGGCC expansion forms RNA G-quadruplex inclusions and sequesters hnRNP H to disrupt splicing in ALS brains. eLife. 2016;5:e17820. doi: 10.7554/eLife.17820.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.17820</ArticleId><ArticleId IdType="pmc">PMC5050020</ArticleId><ArticleId IdType="pubmed">27623008</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y.-B., Chen H.-J., Peres J.N., Gomez-Deza J., Attig J., &#x160;talekar M., Troakes C., Nishimura A.L., Scotter E.L., Vance C., et al. Hexanucleotide repeats in ALS/FTD form length-dependent RNA foci, sequester RNA binding proteins, and are neurotoxic. Cell Rep. 2013;5:1178&#x2013;1186. doi: 10.1016/j.celrep.2013.10.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2013.10.049</ArticleId><ArticleId IdType="pmc">PMC3898469</ArticleId><ArticleId IdType="pubmed">24290757</ArticleId></ArticleIdList></Reference><Reference><Citation>Conlon E.G., Fagegaltier D., Agius P., Davis-Porada J., Gregory J., Hubbard I., Kang K., Kim D., Phatnani H., Kwan J., et al. Unexpected similarities between C9ORF72 and sporadic forms of ALS/FTD suggest a common disease mechanism. eLife. 2018;7:e37754. doi: 10.7554/eLife.37754.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.37754</ArticleId><ArticleId IdType="pmc">PMC6103746</ArticleId><ArticleId IdType="pubmed">30003873</ArticleId></ArticleIdList></Reference><Reference><Citation>Prudencio M., Belzil V.V., Batra R., Ross C.A., Gendron T.F., Pregent L.J., Murray M.E., Overstreet K.K., Piazza-Johnston A.E., Desaro P., et al. Distinct brain transcriptome profiles in C9orf72-associated and sporadic ALS. Nat. Neurosci. 2015;18:1175&#x2013;1182. doi: 10.1038/nn.4065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4065</ArticleId><ArticleId IdType="pmc">PMC4830686</ArticleId><ArticleId IdType="pubmed">26192745</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodman L., Bonini N.M. Repeat-associated non-AUG (RAN) translation mechanisms are running into focus for GGGGCC-repeat associated ALS/FTD. Prog. Neurobiol. 2019;183:101697. doi: 10.1016/j.pneurobio.2019.101697.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2019.101697</ArticleId><ArticleId IdType="pmc">PMC6941355</ArticleId><ArticleId IdType="pubmed">31550516</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmitz A., Marques J.P., Oertig I., Maharjan N., Saxena S. Emerging perspectives on dipeptide repeat proteins in C9ORF72 ALS/FTD. Front. Cell. Neurosci. 2021;15:637548. doi: 10.3389/fncel.2021.637548.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2021.637548</ArticleId><ArticleId IdType="pmc">PMC7930069</ArticleId><ArticleId IdType="pubmed">33679328</ArticleId></ArticleIdList></Reference><Reference><Citation>Saberi S., Stauffer J.E., Jiang J., Garcia S.D., Taylor A.E., Schulte D., Ohkubo T., Schloffman C.L., Maldonado M., Baughn M., et al. Sense-encoded poly-GR dipeptide repeat proteins correlate to neurodegeneration and uniquely co-localize with TDP-43 in dendrites of repeat-expanded C9orf72 amyotrophic lateral sclerosis. Acta Neuropathol. 2018;135:459&#x2013;474. doi: 10.1007/s00401-017-1793-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1793-8</ArticleId><ArticleId IdType="pmc">PMC5935138</ArticleId><ArticleId IdType="pubmed">29196813</ArticleId></ArticleIdList></Reference><Reference><Citation>Schipper L.J., Raaphorst J., Aronica E., Baas F., de Haan R.J., de Visser M., Troost D. Prevalence of brain and spinal cord inclusions, including dipeptide repeat proteins, in patients with the C9ORF72 hexanucleotide repeat expansion: A systematic neuropathological review. Neuropathol. Appl. Neurobiol. 2016;42:547&#x2013;560. doi: 10.1111/nan.12284.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12284</ArticleId><ArticleId IdType="pubmed">26373655</ArticleId></ArticleIdList></Reference><Reference><Citation>Root J., Merino P., Nuckols A., Johnson M., Kukar T. Lysosome dysfunction as a cause of neurodegenerative diseases: Lessons from frontotemporal dementia and amyotrophic lateral sclerosis. Neurobiol. Dis. 2021;154:105360. doi: 10.1016/j.nbd.2021.105360.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2021.105360</ArticleId><ArticleId IdType="pmc">PMC8113138</ArticleId><ArticleId IdType="pubmed">33812000</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen S., Hall B., Castelli L.M., Francis L., Woof R., Siskos A., Kouloura E., Gray E., Thompson A.G., Talbot K., et al. Astrocyte adenosine deaminase loss increases motor neuron toxicity in amyotrophic lateral sclerosis. Brain. 2019;142:586&#x2013;605. doi: 10.1093/brain/awy353.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awy353</ArticleId><ArticleId IdType="pmc">PMC6391613</ArticleId><ArticleId IdType="pubmed">30698736</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen S.P., Hall B., Woof R., Francis L., Gatto N., Shaw A.C., Myszczynska M., Hemingway J., Coldicott I., Willcock A., et al. C9orf72 expansion within astrocytes reduces metabolic flexibility in amyotrophic lateral sclerosis. Brain. 2019;142:3771&#x2013;3790. doi: 10.1093/brain/awz302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz302</ArticleId><ArticleId IdType="pmc">PMC6906594</ArticleId><ArticleId IdType="pubmed">31647549</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaepfel B.L., Rothstein J.D. RNA is a double-edged sword in ALS pathogenesis. Front. Cell. Neurosci. 2021;15:708181. doi: 10.3389/fncel.2021.708181.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2021.708181</ArticleId><ArticleId IdType="pmc">PMC8326408</ArticleId><ArticleId IdType="pubmed">34349625</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold E.S., Ling S.-C., Huelga S.C., Lagier-Tourenne C., Polymenidou M., Ditsworth D., Kordasiewicz H.B., McAlonis-Downes M., Platoshyn O., Parone P.A., et al. ALS-linked TDP-43 mutations produce aberrant RNA splicing and adult-onset motor neuron disease without aggregation or loss of nuclear TDP-43. Proc. Natl. Acad. Sci. USA. 2013;110:E736&#x2013;E745. doi: 10.1073/pnas.1222809110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1222809110</ArticleId><ArticleId IdType="pmc">PMC3581922</ArticleId><ArticleId IdType="pubmed">23382207</ArticleId></ArticleIdList></Reference><Reference><Citation>Donde A., Sun M., Ling J., Braunstein K.E., Pang B., Wen X., Cheng X., Chen L., Wong P.C. Splicing repression is a major function of TDP-43 in motor neurons. Acta Neuropathol. 2019;138:813&#x2013;826. doi: 10.1007/s00401-019-02042-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-02042-8</ArticleId><ArticleId IdType="pmc">PMC6802294</ArticleId><ArticleId IdType="pubmed">31332509</ArticleId></ArticleIdList></Reference><Reference><Citation>Fratta P., Sivakumar P., Humphrey J., Lo K., Ricketts T., Oliveira H., Brito-Armas J.M., Kalmar B., Ule A., Yu Y., et al. Mice with endogenous TDP -43 mutations exhibit gain of splicing function and characteristics of amyotrophic lateral sclerosis. EMBO J. 2018;37 doi: 10.15252/embj.201798684.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201798684</ArticleId><ArticleId IdType="pmc">PMC5983119</ArticleId><ArticleId IdType="pubmed">29764981</ArticleId></ArticleIdList></Reference><Reference><Citation>Jutzi D., Campagne S., Schmidt R., Reber S., Mechtersheimer J., Gypas F., Schweingruber C., Colombo M., von Schroetter C., Loughlin F.E., et al. Aberrant interaction of FUS with the U1 snRNA provides a molecular mechanism of FUS induced amyotrophic lateral sclerosis. Nat. Commun. 2020;11:1&#x2013;14. doi: 10.1038/s41467-020-20191-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-20191-3</ArticleId><ArticleId IdType="pmc">PMC7733473</ArticleId><ArticleId IdType="pubmed">33311468</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling J.P., Pletnikova O., Troncoso J.C., Wong P.C. TDP-43 repression of nonconserved cryptic exons is compromised in ALS-FTD. Science. 2015;349:650&#x2013;655. doi: 10.1126/science.aab0983.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aab0983</ArticleId><ArticleId IdType="pmc">PMC4825810</ArticleId><ArticleId IdType="pubmed">26250685</ArticleId></ArticleIdList></Reference><Reference><Citation>Reber S., Stettler J., Filosa G., Colombo M., Jutzi D., Lenzken S.C., Schweingruber C., Bruggmann R., Bachi A., Barabino S.M., et al. Minor intron splicing is regulated by FUS and affected by ALS -associated FUS mutants. EMBO J. 2016;35:1504&#x2013;1521. doi: 10.15252/embj.201593791.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201593791</ArticleId><ArticleId IdType="pmc">PMC4946139</ArticleId><ArticleId IdType="pubmed">27252488</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun S., Ling S.-C., Qiu J., Albuquerque C.P., Zhou Y., Tokunaga S., Li H., Qiu H., Bui A., Yeo E., et al. ALS-causative mutations in FUS/TLS confer gain and loss of function by altered association with SMN and U1-snRNP. Nat. Commun. 2015;6:1&#x2013;14. doi: 10.1038/ncomms7171.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms7171</ArticleId><ArticleId IdType="pmc">PMC4338613</ArticleId><ArticleId IdType="pubmed">25625564</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q., Conlon E.G., Manley J.L., Rio D.C. Widespread intron retention impairs protein homeostasis in C9orf72 ALS brains. Genome Res. 2020;30:1705&#x2013;1715. doi: 10.1101/gr.265298.120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.265298.120</ArticleId><ArticleId IdType="pmc">PMC7706729</ArticleId><ArticleId IdType="pubmed">33055097</ArticleId></ArticleIdList></Reference><Reference><Citation>White M.A., Kim E., Duffy A., Adalbert R., Phillips B.U., Peters O.M., Stephenson J., Yang S., Massenzio F., Lin Z., et al. TDP-43 gains function due to perturbed autoregulation in a Tardbp knock-in mouse model of ALS-FTD. Nat. Neurosci. 2018;21:552&#x2013;563. doi: 10.1038/s41593-018-0113-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0113-5</ArticleId><ArticleId IdType="pmc">PMC5884423</ArticleId><ArticleId IdType="pubmed">29556029</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin S., Lopez-Gonzalez R., Kunz R.C., Gangopadhyay J., Borufka C., Gygi S.P., Gao F.-B., Reed R. Evidence that C9ORF72 dipeptide repeat proteins associate with U2 snRNP to cause mis-splicing in ALS/FTD Patients. Cell Rep. 2017;19:2244&#x2013;2256. doi: 10.1016/j.celrep.2017.05.056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2017.05.056</ArticleId><ArticleId IdType="pmc">PMC5653973</ArticleId><ArticleId IdType="pubmed">28614712</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon I., Xiang S., Kato M., Wu L., Theodoropoulos P., Wang T., Kim J., Yun J., Xie Y., McKnight S.L. Poly-dipeptides encoded by the C9orf72 repeats bind nucleoli, impede RNA biogenesis, and kill cells. Science. 2014;345:1139&#x2013;1145. doi: 10.1126/science.1254917.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1254917</ArticleId><ArticleId IdType="pmc">PMC4459787</ArticleId><ArticleId IdType="pubmed">25081482</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin C.-L.G., Bristol L.A., Jin L., Dykes-Hoberg M., Crawford T., Clawson L., Rothstein J.D. Aberrant RNA processing in a neurodegenerative disease: The cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis. Neuron. 1998;20:589&#x2013;602. doi: 10.1016/S0896-6273(00)80997-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(00)80997-6</ArticleId><ArticleId IdType="pubmed">9539131</ArticleId></ArticleIdList></Reference><Reference><Citation>Humphrey J., Birsa N., Milioto C., McLaughlin M., Ule A.M., Robaldo D., Eberle A.B., Kr&#xe4;uchi R., Bentham M., Brown A.-L., et al. FUS ALS-causative mutations impair FUS autoregulation and splicing factor networks through intron retention. Nucleic Acids Res. 2020;48:6889&#x2013;6905. doi: 10.1093/nar/gkaa410.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkaa410</ArticleId><ArticleId IdType="pmc">PMC7337901</ArticleId><ArticleId IdType="pubmed">32479602</ArticleId></ArticleIdList></Reference><Reference><Citation>Fratta P., Isaacs A.M. The snowball effect of RNA binding protein dysfunction in amyotrophic lateral sclerosis. Brain. 2018;141:1236&#x2013;1238. doi: 10.1093/brain/awy091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awy091</ArticleId><ArticleId IdType="pmc">PMC5917769</ArticleId><ArticleId IdType="pubmed">29701791</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson J.O., Mandrioli J., Benatar M., Abramzon Y., van Deerlin V.M., Trojanowski J.Q., Gibbs J.R., Brunetti M., Gronka S., Wuu J., et al. Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron. 2010;68:857&#x2013;864. doi: 10.1016/j.neuron.2010.11.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2010.11.036</ArticleId><ArticleId IdType="pmc">PMC3032425</ArticleId><ArticleId IdType="pubmed">21145000</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziff O.J., Taha D.M., Crerar H., Clarke B.E., Chakrabarti A.M., Kelly G., Neeves J., Tyzack G.E., Luscombe N.M., Patani R. Reactive astrocytes in ALS display diminished intron retention. Nucleic Acids Res. 2021;49:3168&#x2013;3184. doi: 10.1093/nar/gkab115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkab115</ArticleId><ArticleId IdType="pmc">PMC8034657</ArticleId><ArticleId IdType="pubmed">33684213</ArticleId></ArticleIdList></Reference><Reference><Citation>Luisier R., Tyzack G.E., Hall C.E., Mitchell J.S., Devine H., Taha D.M., Malik B., Meyer I., Greensmith L., Newcombe J., et al. Intron retention and nuclear loss of SFPQ are molecular hallmarks of ALS. Nat. Commun. 2018;9:1&#x2013;15. doi: 10.1038/s41467-018-04373-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-04373-8</ArticleId><ArticleId IdType="pmc">PMC5964114</ArticleId><ArticleId IdType="pubmed">29789581</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyzack G.E., Neeves J., Crerar H., Klein P., Ziff O., Taha D.M., Luisier R., Luscombe N.M., Patani R. Aberrant cytoplasmic intron retention is a blueprint for RNA binding protein mislocalization in VCP-related amyotrophic lateral sclerosis. Brain. 2021;144:1985&#x2013;1993. doi: 10.1093/brain/awab078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab078</ArticleId><ArticleId IdType="pmc">PMC8370440</ArticleId><ArticleId IdType="pubmed">33693641</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J., Villarreal O.D., Chen X., Zandee S., Young Y.K., Torok C., Lamarche-Vane N., Prat A., Rivest S., Gosselin D., et al. QUAKING regulates microexon alternative splicing of the rho GTPase pathway and controls microglia homeostasis. Cell Rep. 2020;33:108560. doi: 10.1016/j.celrep.2020.108560.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.108560</ArticleId><ArticleId IdType="pubmed">33378678</ArticleId></ArticleIdList></Reference><Reference><Citation>Cestra G., Rossi S., di Salvio M., Cozzolino M. Control of mRNA translation in ALS proteinopathy. Front. Mol. Neurosci. 2017;10:85. doi: 10.3389/fnmol.2017.00085.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00085</ArticleId><ArticleId IdType="pmc">PMC5362592</ArticleId><ArticleId IdType="pubmed">28386218</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehmkuhl E.M., Zarnescu D.C. Lost in translation: Evidence for protein synthesis deficits in ALS/FTD and related neurodegenerative diseases. Adv. Neurobiol. 2018;20:283&#x2013;301. doi: 10.1007/978-3-319-89689-2_11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-319-89689-2_11</ArticleId><ArticleId IdType="pmc">PMC6530776</ArticleId><ArticleId IdType="pubmed">29916024</ArticleId></ArticleIdList></Reference><Reference><Citation>Frottin F., P&#xe9;rez-Berlanga M., Hartl F.U., Hipp M.S. Multiple pathways of toxicity induced by C9orf72 dipeptide repeat aggregates and G4C2 RNA in a cellular model. eLife. 2021;10:e62718. doi: 10.7554/eLife.62718.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.62718</ArticleId><ArticleId IdType="pmc">PMC8221807</ArticleId><ArticleId IdType="pubmed">34161229</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartmann H., Hornburg D., Czuppa M., Bader J., Michaelsen M., Farny D., Arzberger T., Mann M., Meissner F., Edbauer D. Proteomics and C9orf72 neuropathology identify ribosomes as poly-GR/PR interactors driving toxicity. Life Sci. Alliance. 2018;1:e201800070. doi: 10.26508/lsa.201800070.</Citation><ArticleIdList><ArticleId IdType="doi">10.26508/lsa.201800070</ArticleId><ArticleId IdType="pmc">PMC6238541</ArticleId><ArticleId IdType="pubmed">30456350</ArticleId></ArticleIdList></Reference><Reference><Citation>Moens T.G., Niccoli T., Wilson K.M., Atilano M., Birsa N., Gittings L., Holbling B.V., Dyson M., Thoeng A., Neeves J., et al. C9orf72 arginine-rich dipeptide proteins interact with ribosomal proteins in vivo to induce a toxic translational arrest that is rescued by eIF1A. Acta Neuropathol. 2019;137:487&#x2013;500. doi: 10.1007/s00401-018-1946-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1946-4</ArticleId><ArticleId IdType="pmc">PMC6514073</ArticleId><ArticleId IdType="pubmed">30604225</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y., Eshov A., Zhou J., Isiktas A.U., Guo J.U. C9orf72 arginine-rich dipeptide repeats inhibit UPF1-mediated RNA decay via translational repression. Nat. Commun. 2020;11:3354. doi: 10.1038/s41467-020-17129-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-17129-0</ArticleId><ArticleId IdType="pmc">PMC7335171</ArticleId><ArticleId IdType="pubmed">32620797</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanekura K., Yagi T., Cammack A.J., Mahadevan J., Kuroda M., Harms M.B., Miller T.M., Urano F. Poly-dipeptides encoded by the C9ORF72 repeats block global protein translation. Hum. Mol. Genet. 2016;25:1803&#x2013;1813. doi: 10.1093/hmg/ddw052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddw052</ArticleId><ArticleId IdType="pmc">PMC4986334</ArticleId><ArticleId IdType="pubmed">26931465</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Erauskin J., Tadokoro T., Baughn M.W., Myers B., McAlonis-Downes M., Chillon-Marinas C., Asiaban J.N., Artates J., Bui A.T., Vetto A.P., et al. ALS/FTD-linked mutation in FUS suppresses intra-axonal protein synthesis and drives disease without nuclear loss-of-function of FUS. Neuron. 2020;106:354. doi: 10.1016/j.neuron.2020.04.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2020.04.006</ArticleId><ArticleId IdType="pmc">PMC7184958</ArticleId><ArticleId IdType="pubmed">32325059</ArticleId></ArticleIdList></Reference><Reference><Citation>Birsa N., Ule A.M., Garone M.G., Tsang B., Mattedi F., Chong P.A., Humphrey J., Jarvis S., Pisiren M., Wilkins O.G., et al. FUS-ALS mutants alter FMRP phase separation equilibrium and impair protein translation. Sci. Adv. 2021;7 doi: 10.1126/sciadv.abf8660.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abf8660</ArticleId><ArticleId IdType="pmc">PMC8294762</ArticleId><ArticleId IdType="pubmed">34290090</ArticleId></ArticleIdList></Reference><Reference><Citation>Garone M.G., Birsa N., Rosito M., Salaris F., Mochi M., de Turris V., Nair R.R., Cunningham T.J., Fisher E.M.C., Morlando M., et al. ALS-related FUS mutations alter axon growth in motoneurons and affect HuD/ELAVL4 and FMRP activity. Commun. Biol. 2021;4:1&#x2013;17. doi: 10.1038/s42003-021-02538-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-021-02538-8</ArticleId><ArticleId IdType="pmc">PMC8410767</ArticleId><ArticleId IdType="pubmed">34471224</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai A., Valdez-Sinon A.N., Bassell G.J. Regulation of RNA granules by FMRP and implications for neurological diseases. Traffic. 2020;21:454&#x2013;462. doi: 10.1111/tra.12733.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tra.12733</ArticleId><ArticleId IdType="pmc">PMC7377269</ArticleId><ArticleId IdType="pubmed">32374065</ArticleId></ArticleIdList></Reference><Reference><Citation>Higashimori H., Morel L., Huth J., Lindemann L., Dulla C., Taylor A., Freeman M., Yang Y. Astroglial FMRP-dependent translational down-regulation of mGluR5 underlies glutamate transporter GLT1 dysregulation in the fragile X mouse. Hum. Mol. Genet. 2013;22:2041&#x2013;2054. doi: 10.1093/hmg/ddt055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt055</ArticleId><ArticleId IdType="pmc">PMC3633372</ArticleId><ArticleId IdType="pubmed">23396537</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakers K., Lake A.M., Khazanchi R., Ouwenga R., Vasek M.J., Dani A., Dougherty J.D. Astrocytes locally translate transcripts in their peripheral processes. Proc. Natl. Acad. Sci. USA. 2017;114:E3830&#x2013;E3838. doi: 10.1073/pnas.1617782114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1617782114</ArticleId><ArticleId IdType="pmc">PMC5441704</ArticleId><ArticleId IdType="pubmed">28439016</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>